Literature DB >> 24745927

Modification of Lifestyle Factors are Needed to Improve the Metabolic Health of Patients with Cardiovascular Disease Risk.

Linda Landini1.   

Abstract

Cardiovascular risk factors, irregardless of their assessment modalities, are based on cardiovascular health. Lifestyle influences metabolic profiles and these changes affect cardiovascular risk factors. Cardiovascular risk factors can be classified into three basic categories: 1. Predisposing risk factors (e.g., age, gender, medical history, and genetic factors); 2. Clinical and metabolic factors (e.g., hypertension, changes in lipid metabolism, diabetes mellitus, obesity, metabolic syndrome, homocysteine, serum uric acid concetntrations, and L-arginine dimethylated derivatives); 3. Modifying behavioral factors (e.g., cigarette smoking, high caloric diet, alcohol intake, sedentary life). Some of these factors are metabolic components of body metabolism because they act by metabolic reactions while others characterized by structural alterations of the cardiovascular system, at least initially, exert their harmful effects by metabolic substrates. Metabolic responses such as biochemical substances, drugs or others, that act initially as cardiovascular risk factors, identify that an early treatment of the altered parameters observed should be a useful approach to reduce the rate of heart attacks with a significant improvement in the outcome of cardiovascular disease.

Entities:  

Mesh:

Year:  2014        PMID: 24745927     DOI: 10.2174/1381612820666140417094458

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

1.  Neuro-fuzzy model of homocysteine metabolism.

Authors:  Shaik Mohammad Naushad; Akella Radha Rama Devi; Sriraman Nivetha; Ganapathy Lakshmitha; Alex Balraj Stanley; Tajamul Hussain; Vijay Kumar Kutala
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

2.  Inverse associations between serum urate and glycemic status in a general population and in persons with diabetes mellitus.

Authors:  Ichiro Wakabayashi
Journal:  Diabetol Metab Syndr       Date:  2020-03-10       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.